Development of precision medicine approaches based on inter-individual variability of BCRP/ABCG2

Development of precision medicine approaches based on inter-individual variability of BCRP/ABCG2

Precision medicine is a rapidly-developing modality of medicine in human healthcare. Based on each patient׳s unique characteristics, more accurate dosages and drug selection can be made to achieve better therapeutic efficacy and less adverse reactions in precision medicine. A patient׳s individual pa...

Full description

Bibliographic Details
Main Authors:	Liming Chen, Jose E. Manautou, Theodore P. Rasmussen, Xiao-bo Zhong
Format:	Article
Language:	English
Published:	Elsevier 2019-07-01
Series:	Acta Pharmaceutica Sinica B
Online Access:	http://www.sciencedirect.com/science/article/pii/S2211383518309158

Similar Items

Chicken xenobiotic receptor upregulates the BCRP/ABCG2 transporter
by: Ziyong Xu, et al.
Published: (2023-01-01)

Expression of ABCG2 (BCRP) in mouse models with enhanced erythropoiesis
by: Gladys Oluyemisi Latunde-Dada, et al.
Published: (2014-06-01)

BCRP/ABCG2 inhibition sensitizes hepatocellular carcinoma cells to sorafenib.
by: Wei-Chien Huang, et al.
Published: (2013-01-01)

Gene and functional up-regulation of the BCRP/ABCG2 transporter in hepatocellular carcinoma
by: Sukowati Caecilia HC, et al.
Published: (2012-11-01)

Effects of α-adrenoceptor antagonists on ABCG2/BCRP-mediated resistance and transport.
by: Kohji Takara, et al.
Published: (2012-01-01)

Effect of ABCG2/BCRP Expression on Efflux and Uptake of Gefitinib in NSCLC Cell Lines.
by: Maricla Galetti, et al.
Published: (2015-01-01)

In silico prediction of inhibition of promiscuous breast cancer resistance protein (BCRP/ABCG2).
by: Yi-Lung Ding, et al.
Published: (2014-01-01)

Evaluation of mRNA Expression Profile of ABCG2/BCRP in Childhood Acute Lymphoblastic Leukemia
by: M Entezar-e-Ghaem, et al.
Published: (2013-12-01)

Modulating drug resistance by targeting BCRP/ABCG2 using retrovirus-mediated RNA interference.
by: Ni Xie, et al.
Published: (2014-01-01)

Extra-renal elimination of uric acid via intestinal efflux transporter BCRP/ABCG2.
by: Atsushi Hosomi, et al.
Published: (2012-01-01)

Interplay of Breast Cancer Resistance Protein (Bcrp/Abcg2), Sex, and Fed State in Oral Pharmacokinetic Variability of Furosemide in Rats
by: Sheena Sharma, et al.
Published: (2023-02-01)

Extracellular Vesicles as Surrogates for the Regulation of the Drug Transporters ABCC2 (MRP2) and ABCG2 (BCRP)
by: Juan Pablo Rigalli, et al.
Published: (2024-04-01)

Correction: Modulating Drug Resistance by Targeting BCRP/ABCG2 Using Retrovirus-Mediated RNA Interference
Published: (2014-01-01)

ABCG2/BCRP transport mechanism revealed through kinetically excited targeted molecular dynamics simulations
by: B. Dudas, et al.
Published: (2022-01-01)

Jump into a New Fold-A Homology Based Model for the ABCG2/BCRP Multidrug Transporter.
by: Laura László, et al.
Published: (2016-01-01)

Interactions of ABCG2 (BCRP) with epidermal growth factor receptor kinase inhibitors developed for molecular imaging
by: Israa eAbdelrahman, et al.
Published: (2014-11-01)

Clinical Significance of ABCG2/BCRP Quantified by Fluorescent Nanoparticles in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy
by: Hiroshi Tada, et al.
Published: (2023-04-01)

Human ABC transporter ABCG2/BCRP expression in chemoresistance: basic and clinical perspectives for molecular cancer therapeutics
by: Noguchi K, et al.
Published: (2014-02-01)

Elevated BCRP/ABCG2 expression confers acquired resistance to gefitinib in wild-type EGFR-expressing cells.
by: Yun-Ju Chen, et al.
Published: (2011-01-01)

The Pyrazolo[3,4-d]pyrimidine Derivative, SCO-201, Reverses Multidrug Resistance Mediated by ABCG2/BCRP
by: Sophie E. B. Ambjørner, et al.
Published: (2020-03-01)

Hedgehog Pathway Inhibitor HhAntag691 Is a Potent Inhibitor of ABCG2/BCRP and ABCB1/Pgp
by: Yimao Zhang, et al.
Published: (2009-01-01)

The inhibition of ABCB1/MDR1 or ABCG2/BCRP enables doxorubicin to eliminate liver cancer stem cells
by: Wang Yin, et al.
Published: (2021-05-01)

Correction: PTEN Regulates BCRP/ABCG2 and the Side Population through the PI3K/Akt Pathway in Chronic Myeloid Leukemia
Published: (2014-01-01)

Correction: PTEN Regulates BCRP/ABCG2 and the Side Population through the PI3K/Akt Pathway in Chronic Myeloid Leukemia.
Published: (2014-01-01)

Breast Cancer Resistance Protein (BCRP/<i>ABCG2</i>) Inhibits Extra Villous Trophoblast Migration: The Impact of Bacterial and Viral Infection
by: Phetcharawan Lye, et al.
Published: (2019-09-01)

CORRELATION BETWEEN CHEMOTHERAPY RESPONSE AND EXPRESSION PROFILES OF TRANSMEMBRANE PROTEINS: P-GLYCOPROTEIN (ABCB1), MRP2 (ABCC2), BCRP (ABCG2) IN PATIENTS WITH INVASIVE BREAST CANCER
by: К. Yu. Khristenko, et al.
Published: (2016-10-01)

Association between DNA methylation in the miR-328 5'-flanking region and inter-individual differences in miR-328 and BCRP expression in human placenta.
by: Jumpei Saito, et al.
Published: (2013-01-01)

Relative roles of ABCG5/ABCG8 in liver and intestine[S]
by: Jin Wang, et al.
Published: (2015-02-01)

Characterization of a Potent, Selective, and Safe Inhibitor, Ac15(Az8)<sub>2</sub>, in Reversing Multidrug Resistance Mediated by Breast Cancer Resistance Protein (BCRP/ABCG2)
by: Tsz Cheung Chong, et al.
Published: (2022-10-01)

ABCG5 and ABCG8 gene variations associated with sitosterolemia and platelet dysfunction
by: Jose María Bastida, et al.
Published: (2021-05-01)

Reversal of ABCG2/BCRP-Mediated Multidrug Resistance by 5,3′,5′-Trihydroxy-3,6,7,4′-Tetramethoxyflavone Isolated from the Australian Desert Plant <i>Eremophila galeata</i> Chinnock
by: Malene J. Petersen, et al.
Published: (2021-10-01)

ABCG5 and ABCG8 Are Involved in Vitamin K Transport
by: Michinori Matsuo, et al.
Published: (2023-02-01)

Functional Cooperativity between ABCG4 and ABCG1 Isoforms.
by: Zoltán Hegyi, et al.
Published: (2016-01-01)

Magnolol and Honokiol Inhibited the Function and Expression of BCRP with Mechanism Exploration
by: Chung-Ping Yu, et al.
Published: (2021-12-01)

The Effect of Albumin on MRP2 and BCRP in the Vesicular Transport Assay.
by: Feng Deng, et al.
Published: (2016-01-01)

P-Glycoprotein (ABCB1/MDR1) and BCRP (ABCG2) Limit Brain Accumulation and Cytochrome P450-3A (CYP3A) Restricts Oral Exposure of the RET Inhibitor Selpercatinib (RETEVMO)
by: Yaogeng Wang, et al.
Published: (2021-10-01)

Selective sterol accumulation in ABCG5/ABCG8-deficient mice
by: Liqing Yu, et al.
Published: (2004-02-01)

TRPS1 Confers Multidrug Resistance of Breast Cancer Cells by Regulating BCRP Expression
by: Jing Hu, et al.
Published: (2020-06-01)

Cannabidiol changes P-gp and BCRP expression in trophoblast cell lines
by: Valeria Feinshtein, et al.
Published: (2013-09-01)

ABCG5 and ABCG8 require MDR2 for secretion of cholesterol into bile
by: Silvia Langheim, et al.
Published: (2005-08-01)